English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Widimsk ̆ J, Vanûk P*, JuráÀ F**, Lánská V*** (Klinika kardiologie, Institut klinické a experimentální medicíny, Praha, *Konstantinovy Láznû, **Láznû Teplice nad Beãvou, ***Statistické oddûlení, Institut klinické a experimentální medicíny, Praha, âeská republika). Stav kardiovaskulární farmakoterapie u nemocn ̆ch po infarktu myokardu a/nebo revaskularizaci myokardu v roce 2005 v âeské republice. V ̆voj za 5 a 10 let. Cor Vasa 2006;48(4):135–141.

cor et vasa

Current status of cardiovascular pharmacotherapy in patients after myocardial infarction and/or revascularization in the Czech Republic in 2005. Developments seen during the past 5 and 10 years